Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clevidipine for Vasospasm After Subarachnoid Hemorrhage

NCT02011321 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT02011321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02011321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clevidipine for Vasospasm After Subarachnoid Hemorrhage
Lead sponsor
Henry Ford Health System
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2014
Completion date
September 30, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral aneurysm, subarachnoid hemorrhage, vasospasm, intracranial